4893 items matching your search terms.

Impact of cholesterol lowering treatment with pravastatin in diabetic CHD patients

Tonkin, A.; Hunt, D.; MacMahon, S.; Keech, A.C.; Simes, J.

The LIPID trial: Impact of lipid lowering therapy with pravastatin on the risk of stroke

White, H.D. Simes, R.J. Watson, J. Anderson, N. Hankey, G. Simes, S. Tonkin, A.

The LIPID trial: impact of lipid lowering therapy with pravastatin on the risk of stroke. The LIPID Study Group

White, H.; Simes, R.J.; Watson, J. D.; Anderson, N. E.; Hankey, G. J.; Simes, S.; Tonkin, A.

Asymptomatic metastatic colorectal cancer cohort study: use of a register to assess recruitment and applicability of a randomised trial

Yuen, J; Lundie-Jenkins, H; Ackland, S; Solomon, M; Goldstein, D; Simes, RJ

Utility of a bedside hemochron JR monitor compared with laboratory control of APTT for anticoagulant therapy

Aroney, G. Hamer, A. Tonkin, A. Nelson, G. Federman, J. Moliterno, D. Aylward, P. Arulchelvam, M. Keech, A.C.

PARAGON A: Platelet IIb/IIIa antagonist for the reduction of acute coronary syndrome events in a global organisation network

Aylward, P.; Keech, A.C.; Simes, J.; White, H.D.

Treatment monitoring

Baker, J. Ghersi, D. Petersen-Schaefer, K.

Risk factors for coronary heart disease mortality in patients with documented CHD: evidence from the LIPID study

Baker, J.; Simes, R.J.; Colquhoun, D.; Hague, W.; Hunt, D.; Tonkin, A.; LIPID Study Investigators,

Does waiting time affect the outcome of larynx cancer treated by radiotherapy?

Barton, MB Morgan, G Smee, R Tiver, KW Hamilton, C Gebski, V

Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: a randomised placebo-controlled trial. Australasian Megestrol Acetate Cooperative Study Group

Beller, E; Tattersall, M; Lumley, T; Levi, J; Dalley, D; Olver, I; Page, J; Abdi, E; Wynne, C; Friedlander, M; Boadle, D; Wheeler, H; Margrie, S; Simes, RJ

Long-term perspective on premature infant outcome and contemporary intervention issues

Bennett, FC Scott, DT
SEMINARS IN PERINATOLOGY, 1997     DOI:doi:10.1016/S0146-0005(97)80063-8

Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials Group

Byrne, MJ; Gebski, V; Forbes, J; Tattersall, MH; Simes, RJ; Coates, AS; Dewar, J; Lunn, M; Flower, C; Gill, PG; Stewart, J

Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I Investigators

Califf, RM; Woodlief, LH; Harrell, FE, Jr; Lee, KL; White, HD; Guerci, A; Barbash, GI; Simes, RJ; Weaver, WD; Simoons, ML; Topol, EJ

Meta-analysis, collaborative overview, systematic review: what does it all mean?

Clarke, M. Ghersi, D.

Marginal analysis of recurrent events and a terminating event

Cook, R Lawless, J
STATISTICS IN MEDICINE, 1997     DOI:doi:10.1002/(SICI)1097-0258(19970430)16:8<911::AID-SIM544>3.0.CO;2-I